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Abstract  
Different tissues contain diverse and dynamic cellular niches, providing distinct signals 
to tissue-resident or migratory, infiltrating immune cells.  Hedgehog (Hh) proteins are 
secreted inter-cellular signalling molecules, which are essential during development and 
are important in cancer, post-natal tissue homeostasis and repair. Hh signalling, via the 
Hh-responsive transcription factor Gli2, also has multiple roles in T-lymphocyte 
development and differentiation.  Here we investigate the function of Gli2 in T-cell 
signalling and activation.  Gene transcription driven by the Gli2 transcriptional activator 
(Gli2A) attenuated T-cell activation and proliferation following T-cell receptor (TCR) 
stimulation.  Expression of Gli2A in T-cells altered gene expression profiles, impaired 
the TCR-induced calcium flux and nuclear expression of NFAT, suppressed 
upregulation of molecules essential for activation, and attenuated signalling pathways 
upstream of AP-1 and NFκB, leading to reduced activation of these important 
transcription factors.  Inhibition of physiological Hh-dependent transcription increased 
NFκB activity on TCR ligation.  These data have importance for understanding 
molecular mechanisms of immunomodulation, particularly in tissues where Hh proteins 
or other Gli-activating ligands such as TGFβ are upregulated, including during 
inflammation, tissue damage and repair, or in tumour microenvironments.   
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Introduction 
Peripheral T-cell activation, differentiation and clonal expansion are controlled by 
complex signals, which are initiated by interaction of the T-cell receptor (TCR) with 
MHC-peptide ligand.  For full activation, T-cells require co-stimulation by binding of 
CD28 to CD80/CD86 on antigen presenting cells (APC).  TCR and CD28 ligation lead 
to a series of TCR-proximal phosphorylation events, the release of intracellular calcium 
stores and triggering of signalling cascades, which activate key transcription factors 
including AP-1, NFAT and NFκB (Huse, 2009).  The transcriptional response to TCR 
signalling controls the subsequent activation and resolution of the adaptive immune 
response (Thompson et al., 1989; Smith-Garvin et al., 2009; Cheng et al., 2011).  
Interleukin-2 (IL-2) is a potent growth factor for T-cells in vitro and in vivo (Smith, 
1988; Boyman and Sprent, 2012).  Activation of T-cells induces synthesis of IL-2 and 
upregulation of cell-surface CD25 (IL-2Rα), the high-affinity IL-2 receptor subunit, this 
providing a feedback loop, which enhances IL-2 signalling.  Persistent stimulation of T-
cells via TCR and IL-2 signalling eventually induces apoptotic pathways, resulting in 
activation-induced cell death (AICD).  The function of TCR/CD28 and cytokine 
signalling in T-cell activation is well characterised, although the role of other 
microenvironmental cues in altering local T-cell responses is not well understood.  
Different secondary lymphoid organs, distinct tissue niches and solid neoplasms each 
present diverse and dynamic cellular microenvironments, which may provide different 
signals to local resident or infiltrating T-cells.  The influence of non-immune, tissue-
derived molecules on T-cell activation therefore requires investigation. 
 
Hedgehog (Hh) proteins are secreted inter-cellular signalling molecules essential for 
patterning during foetal development and homeostasis of adult tissues (Neumann, 2005; 
Ingham and Placzek, 2006; Agathocleous et al., 2007; Crompton et al., 2007; Jiang and 
Hui, 2008; Le et al., 2008).  Hh pathway molecules are expressed in thymus (Outram et 
al., 2000; Sacedon et al., 2003), where Hh signalling regulates multiple stages of T-cell 
development (Outram et al., 2000; Shah et al., 2004; Hager-Theodorides et al., 2005; El 
Andaloussi et al., 2006; Rowbotham et al., 2007; Rowbotham et al., 2008; Hager-
Theodorides et al., 2009; Rowbotham et al., 2009; Drakopoulou et al., 2010; Furmanski 
et al., 2012; Michel et al., 2013).  Gene expression studies have shown that mature 
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splenic T-cells express Hh signal transduction molecules Ptch and Smo (Lowrey et al., 
2002; Furmanski et al., 2013).  Desert Hh (Dhh) is expressed in spleen (Perry et al., 
2009; Lau et al., 2012), and Sonic Hh (Shh) is produced by follicular dendritic cells in 
spleen and lymph nodes (Sacedon et al., 2005), and by the stroma of several tissues 
(Sato et al., 1999; Pola et al., 2003; Nielsen et al., 2004; Furmanski et al., 2013).  Many 
tumours secrete Hh ligands, and the pathway is active in wound repair and fibrotic 
diseases (Jiang and Hui, 2008; Le et al., 2008).   
 
Canonical mammalian Hh signalling is initiated by the binding of Shh, Dhh or Ihh to 
the cell surface receptor Patched1 (Ptch) (Marigo et al., 1996).  This interaction relieves 
inhibition of Smoothened (Smo), the Hh-signalling transduction molecule (Alcedo et 
al., 1996), which activates members of the Gli family of transcription factors (Varjosalo 
and Taipale, 2007).  Gli proteins bind to DNA at consensus Gli-family binding sites and 
directly modulate target gene transcription.  Gli2 is necessary to initiate the Hh signal 
and acts mainly as a transcriptional activator in vivo, but can be processed into 
truncated isoforms of the full-length Gli2 protein, which activate (Gli2A) or repress 
(Gli2R) transcription (Aza-Blanc et al., 2000; Bai et al., 2002).  Hh ligand binding 
blocks production of Gli2R, and full-length Gli2 proteins are converted to Gli2A, 
altering the cellular ratio of Gli2R:Gli2A, which regulates the cellular response Hh 
signals.  In the absence of ligand, a significant proportion of transcriptionally-inactive 
Gli2 remains in the cytoplasm.  Gli1 can function only as a transcriptional activator and 
is itself a transcriptional target of Gli2A.  All Gli proteins contain a nuclear localisation 
signal (NLS) and nuclear export signal (NES), which control movement between the 
nucleus and cytoplasm.  Upon Hh ligand binding, Gli2A accumulates in the nucleus to 
activate Hh-dependent transcription (Kim et al., 2009; Hatayama and Aruga, 2012).  
Interestingly, Gli2 has also been shown to be responsive to TGFβ signal transduction in 
several cell types (Dennler et al., 2007), and Gli2A function can also be regulated by 
Akt/PI3k and EGF signalling (Kasper et al., 2006; Riobo et al., 2006). 
 
Here we show that Gli transcription factors are present in the nucleus and cytoplasm of 
wild-type (WT) splenic CD4+ cells.  To investigate how Gli2-mediated transcription 
influences TCR signalling in CD4+ T-cells, we used transgenic models where 
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transcription of target genes by Gli2 is either constitutively active (Gli2A) or repressed 
(Gli2R) (Rowbotham et al., 2007; Rowbotham et al., 2008).  The Gli2A and Gli2R 
transgenes are driven by the Lck promoter and so are expressed in T-lineage cells only 
(Buckland et al., 2000; Shimizu et al., 2001).  The transgenes are otherwise identical in 
sequence and share the zinc finger domains that bind to DNA at consensus Gli binding 
sites.     
   
We show that the ability of T-cells to signal, activate, proliferate and respond to IL-2 is 
impaired in the presence of Gli2A.  Our data indicate that Gli2-dependent transcription 
attenuates T-cell activation by altering the expression of genes important for several key 
signalling events downstream of TCR ligation.  This has implications for our 
understanding of immune regulation in tissues that express ligands able to activate Gli-
dependent transcription.   
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Results 
Gli transcription factors are expressed in WT T-cells 
To show that WT T-cells express the essential Hh-responsive transcription factor Gli2, 
we investigated Gli2 protein expression and localisation by Western blot in CD4+ cells 
purified from spleen (Fig. 1A).   Gli2 was expressed in the cytoplasm and nucleus of ex 
vivo unstimulated WT CD4+ lymphocytes.  Nuclear accumulation of Gli2A is 
associated with active Hh signalling (Kim et al., 2009), therefore we investigated 
expression of Gli1, a canonical Gli2-target and transcriptional activator.  Gli1 protein 
was also present in WT CD4+ T-cells.  The presence of Gli1 protein and nuclear 
localisation of Gli2 suggest that there is Gli transcriptional activity in WT CD4+ T-
cells.  These data support the observation that differentiated CD8+ cytotoxic T-cells 
express Ptch and Gli1 protein (de la Roche et al., 2013). 
We then examined Gli expression in T-cells from Gli2A transgenic mice.  Gli2 and Gli1 
were expressed in Gli2A T-cells (Fig. 1A).  The ratio of nuclear to cytoplasmic Gli2 
was higher in the Gli2A transgenic compared to WT CD4+ T-cells, consistent with the 
transgenic expression of a transcriptional activator.  Interestingly, we did not observe an 
increase in nuclear Gli1 protein in the Gli2A cells compared to WT, despite the fact that 
Gli1 transcript (and also Ptch1 transcript) is upregulated in the transgenic cells 
(Rowbotham et al., 2007; Furmanski et al., 2013).  The Gli transcription factors have 
distinct tissue-specific functions (Mo et al., 1997; Matise et al., 1998; Bai et al., 2002) 
and in many tissues it has only been possible to identify a function for Gli1 when Gli2 is 
mutated (Park et al., 2000).  Our data show that in T-cells, increased Gli2A protein does 
not lead to a corresponding increase in nuclear Gli1 protein, suggesting that regulatory 
feedback mechanisms influence protein levels.   This would be consistent with the fact 
that Gli1 deficiency makes little functional impact unless Gli2 is absent. 
 
Given that WT CD4+ cells express Gli2 and Gli1 directly ex vivo, and that Gli2 
localised to the nucleus, we investigated the influence of Gli2 transcriptional activity on 
CD4+ T-cell phenotype and function.   
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Phenotype of T-cells expressing Gli2A  
We compared the CD4+ cell phenotype of WT mice and Gli2A transgenic mice, which 
overexpress the activator form of Gli2 in T-cells.  Compared to WT, CD4+ T-cell 
numbers in Gli2A spleen were not significantly different to that of WT (Fig. 1B) and ex 
vivo, these T-cells expressed similar levels of the TCR-associated signalling molecule, 
CD3 and low levels of the early activation marker, CD69 (Fig. 1C).  Interestingly, 
compared to WT, a lower proportion of Gli2A CD4+ cells were CD62L+CD44- (Fig. 
1D), a phenotype associated with naïve T-cells.  However, there was no equivalent 
increase in CD44+ cells (effector memory, EM or central memory, CM) in Gli2A 
spleen (Fig. 1E), suggesting that Gli2A does not alter the distribution of T-cells among 
naïve and memory subsets.  CD62Llo/-CD44- cells are seen in the Gli2A CD4+ 
population.  Such cells are not readily detectable in WT spleen.    Instead we observed 
that the presence of Gli2A in CD4+ T-cells downregulated the level of surface CD62L 
(Fig. 1F).   
 
Gli2A negatively regulates T cell activation and proliferation 
We then examined expression of the activation marker CD25 on CD4+ cells treated 
with anti-CD3/CD28 through a three day time-course.  In response to stimulation, 
Gli2A CD4+ cells were less able to upregulate surface CD25 (Fig. 2A,B) than WT cells 
at any time point examined, suggesting that activation of Gli2A T-cells is defective with 
slower kinetics throughout the response.   
We therefore assessed Gli2A CD4+ cell proliferation following CD3/CD28 ligation.  
We cultured WT and Gli2A CFSE-labelled splenocytes with anti-CD3/CD28 and 
analysed dye dilution at 72 hours.  Consistent with impaired activation, we observed 
proportionally fewer CFSElow peaks compared to WT cells (Fig. 2C) and an increased 
percentage of undivided CFSEhi CD4+ cells (Fig. 2C,D) in Gli2A cultures compared to 
WT.  These data complement our previous findings that T-cell-specific repression of 
Gli-dependent transcription increased TCR-driven T-cell activation and proliferation 
(Rowbotham et al., 2008). 
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Gli-dependent transcription alters cell survival 
Our data show that Gli-dependent transcription influences T-cell activation and 
proliferation (Fig.  2 and (Rowbotham et al., 2007; Rowbotham et al., 2008)).  
Population expansion is a dynamic process and the overall outcome will depend on the 
balance between activation, division and cell death. We therefore investigated apoptosis 
in Gli2A activation cultures by assessing cell surface binding of Annexin V (AnnV), a 
marker of membrane-flipping during early apoptosis.  A higher percentage of Gli2A 
CD4+ cells bound AnnV relative to WT after 24 h in activation cultures, indicating an 
increased proportion of cells undergoing the early stages of apoptosis (Fig. 3A).  In 
order to determine whether this applied only to death of activated T-cells, we stained 
control, unstimulated splenocyte cultures at 72 h with AnnV.  Again, Gli2A CD4+ cell 
populations displayed greater AnnV staining than WT, indicating increased apoptosis 
(Fig. 3B).  To further investigate, we measured Propidium Iodide (PI) staining in WT 
and Gli2A CD4+ lymphocytes after 24 h in culture with increasing anti-CD3/CD28 
dose (Fig. 3C).  PI is actively excluded from live cells: PI uptake represents membrane 
permeability and late-stage apoptosis.  As with AnnV, we noted an increased proportion 
of cells undergoing apoptosis in unstimulated and stimulated (0.01µg/ml) Gli2A 
cultures compared to WT.  Interestingly, as anti-CD3/CD28 dose increased log-fold we 
observed large increases in PI staining in Gli2A CD4+ cells indicating widespread 
apoptosis in the cultures, whereas the majority of WT cells were still able to exclude PI.       
Together these data suggest that Gli-dependent transcription in T-cells impairs cell 
survival and increases the likelihood of cell death.     
 
Gli2 activity impairs IL-2 production by activated T-cells 
T-cell activation stimulates the production of IL-2, a potent T-cell growth and survival 
factor.  As Gli2A cells display attenuated activation, a proliferation defect and an 
increased tendency to undergo apoptosis, we tested the capability of Gli2A cells to 
produce IL-2.  After a short mitogenic stimulation of splenocytes directly ex vivo, we 
found that significantly fewer CD4+ Gli2A cells expressed intracellular IL-2 compared 
to WT (Fig. 3D).  To confirm that this effect was cell-intrinsic and not due to bystander 
effects from other splenocytes, we purified CD4+ T-cells and cultured them with anti-
CD3/CD28-coated beads for 72 h.  We found that compared to WT, a lower proportion 
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of Gli2A cells expressed intracellular IL-2 at 48 h (Fig. 3E).  Strikingly, IL-2hiCD25+ 
cells, which are likely to be fully activated and signalling in an autocrine/paracrine 
manner, were significantly diminished in Gli2A cultures compared to WT (Fig. 3E) at 
both 48 h and 72 h.  Gli2A culture supernatants contained less IL-2 protein than WT 
cultures as measured by ELISA at 24 h, 48 h and 72 h.  This was most pronounced and 
statistically significant at 48h (Fig. 3F). 
 
 
Exogenous IL-2 does not rescue the phenotype of Gli2A cells      
Activated Gli2A cells produce less IL-2 than WT cells, and show decreased 
proliferation and increased apoptosis.  To test whether this phenotype can be rescued by 
exogenous IL-2, we performed proliferation experiments where cells were cultured with 
anti-CD3/CD28 in the presence or absence of recombinant-IL-2 (rIL-2).  Addition of 
rIL-2 did not affect the proportions of dividing cells in WT or Gli2A cultures after 48 h 
(Fig. 4A).  By 72 h the presence of rIL-2 had significantly enhanced the proliferation 
and/or survival of WT cells (Fig. 4A). However, we observed no significant 
enhancement in proliferation of Gli2A cells when exogenous IL-2 was added.  We 
calculated the relative number of cells having divided more than twice by 72 h, and 
compared this between samples cultured with and without exogenous IL-2.  In WT 
cultures, we found that approximately three-fold more cells had undergone multiple 
divisions when IL-2 was added together with anti-CD3/CD28, compared to anti-
CD3/CD28 alone.  However, this was not observed in Gli2A cultures (Fig. 4B). 
To assess the impact of rIL-2 on maintenance of our cultures, we assessed cell viability 
and number.  At 72 h, all Gli2A cultures displayed lower numbers of CD4+ cells 
compared to WT (Fig. 4C).  The highest cell numbers were observed in WT cultures 
treated with anti-CD3/CD28 and rIL-2.  However, there was a marked decrease in 
CD4+ cell number in the equivalent Gli2A cultures (Fig. 4C).   
These data indicate that IL-2 responsiveness is attenuated when Gli2-dependent 
transcription is active.  Gli2A cells proliferate less well than WT cells (Fig. 2) and 
produce less IL-2 upon TCR stimulation (Fig. 3), and their proliferation defect cannot 
be rectified by the addition of exogenous IL-2.  In contrast to WT cells, Gli2A cells do 
not fully upregulate CD25 upon activation (Fig. 2A,B).  CD25 is an important subunit 
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of the high-affinity receptor for IL-2. Therefore as CD25 upregulation is lower on 
Gli2A than on WT cells, it seems likely that Gli2A cells express a lower density of 
high-affinity IL-2R on the cell surface than WT.  IL-2, either added to or produced by 
Gli2A cells in culture may therefore be saturating due to decreased IL-2R availability.  
Alternatively, Gli2A cells may have defective intracellular IL-2/IL-2R signalling.   
 
Gli2 activity does not affect the ability of CD4+ cells to transduce IL-2 signals via 
STAT5 
To determine whether Gli2A cells are less able to transduce IL-2 signals independent of 
TCR signalling and subsequent CD25 upregulation (i.e in the presence of IL-2 alone, 
without any other T-cell stimulation), we cultured fresh splenocytes directly ex vivo for 
15 minutes with recombinant IL-2 and measured expression of intracellular 
phosphorylated Signal Transduction and Activator of Transcription 5 (pSTAT5), a 
major transcription factor that is activated downstream of IL-2 signalling (Gilmour et 
al., 1995).  We found no significant difference in the proportion of cells expressing 
pSTAT5 between WT and Gli2A CD4+ cells (Fig. 4D), suggesting that Gli2A cells do 
not have an inherent inability to transduce IL-2 signals that result in phosphorylation of 
STAT5.  To assess the impact of T-cell activation on STAT5 phosphorylation in WT 
and Gli2A cells, we measures pSTAT5 levels in CD4+ cells from activation cultures 
(Fig. 4E).  As expected, unstimulated and anti-CD3/CD28-stimulated CD4+ cells 
showed similar pSTAT5 expression in WT and Gli2A cultures. However, we noted a 
marked decrease in pSTAT5 expression in Gli2A cells from cultures stimulated with 
anti-CD3/CD28 in the presence of IL-2.  These experiments indicate that the inability of 
Gli2A T-cells to upregulate CD25 and proliferate efficiently on CD3/CD28 ligation is 
not simply the result of reduced IL2 signalling, but is rather the direct influence of Gli-
mediated transcription on TCR/CD28 driven cell activation.  We therefore investigated 
TCR signalling in this model.   
 
Gli2-driven transcription regulates the T-cell calcium flux 
Upon TCR ligation, T-cells undergo a sustained influx of calcium ions (Ca2+) across the 
plasma membrane, which stimulates the release of Ca2+ from intracellular stores, 
triggering signalling pathways and the activation of transcription factors including 
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NFκB and NF-AT.  Impaired calcium flux has been shown to diminish events 
downstream of TCR activation necessary for proliferation and survival, including IL-2 
production (Feske, 2007).  In order to determine whether Gli-dependent transcription 
influences the calcium flux, we activated Gli2A T-cells and monitored Ca2+ entry into 
cells loaded with Fluo-4-AM, a calcium-binding fluorescent dye.  Baseline fluorescence 
was measured for 60s prior to TCR stimulation.  We observed a sustained calcium flux 
in WT T-cells following cross-linking of surface CD3 molecules (Fig. 5A, upper 
panels).  In comparison, Gli2A cells showed a diminished flux of lower magnitude (Fig. 
5A-C).  Gli2A cells were able to undergo a calcium flux comparable to WT cells upon 
stimulation with ionomycin, a calcium ionophore (Fig. 5A, lower panels), indicating 
that the impaired fluxes seen with anti-CD3 activation were due to defective TCR 
signalling.   
NFAT transcription factors are critical regulators of T-cell function during activation.  
TCR-induced calcium flux triggers dephosphorylation and translocation of NFAT 
proteins to the nucleus, where they modulate T-cell transcription.  In order to assess 
whether the impaired calcium flux in Gli2A cells affected nuclear expression of NFAT, 
we performed Western blotting for NFAT2 on nuclear extracts of WT and Gli2A CD4+ 
cells following anti-CD3/CD28 stimulation (Fig. 5D).  As expected given their weak Ca 
flux, Gli2A cells showed lower expression of nuclear NFAT after stimulation.   
Our data show that Gli2, a transcription factor that is expressed in WT cells, modulates 
T-cell biology via mechanisms downstream of the TCR.  We therefore sought to 
examine the transcriptional mechanisms involved in the influence of Gli-dependent 
transcription on TCR signalling during the early stages of T-cell activation.      
 
Expression of Gli proteins in Gli2R CD4+ T-cells  
We have shown that Gli2A cells highly express Gli2 protein in T-cell nuclear extracts 
(Fig. 1A).  These cells also constitutively express high levels of Ptch1 transcript, a Hh-
target gene (Furmanski et al., 2013).  Additionally, we have shown that Gli2R 
transgenic CD4+ cells are refractory to upregulation of Ptch1 on Shh treatment 
(Rowbotham et al., 2008), and therefore that physiological Hh signalling is inhibited in 
these cells.  In contrast to Gli2A cells, T-cells from Gli2R transgenic mice show an 
enhanced activation phenotype compared to WT controls, and displayed increased 
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proliferation after 72 h in culture with anti-CD3/CD28 (Rowbotham et al., 2008).  
Gli2A and Gli2R proteins are isoforms of the same transcription factor but may reside 
in different cellular locations due to their distinct functions.  We therefore investigated 
Gli2 protein expression in Gli2R CD4+ cells by Western blotting of cell extracts.  As 
expected, Gli2R cells expressed Gli2 (Fig. 6A).  Interestingly, there was a lower nuclear 
to cytoplasmic ratio of Gli2 compared to WT cells, and Gli2R cells also displayed lower 
abundance of Gli1 protein, itself a canonical Gli-target (Fig. 6A), reflecting the 
repressor function of the transcription factor. 
 
Regulation of CD4+ T-cell transcription by Gli2 
We have shown that Gli proteins are expressed in WT T-cells, and that the Gli2A and 
Gli2R transgenes modulate T-cell transcription and function.  We therefore investigated 
which genes are regulated by Gli2 in lymphocytes during TCR stimulation.  We 
measured Gli2-dependent transcription in fresh and anti-CD3/CD28-activated CD4+ T-
cells from spleen of WT, Gli2A and Gli2R mice by microarray (GSE33156, GEO 
depository) as described (Furmanski et al., 2013).  We analysed the resting and TCR-
stimulated T-cell data sets separately in order to identify genes regulated by Gli2 in both 
the absence and presence of a TCR signal.  Gene lists were obtained from normalised 
fold-change analyses or by moderated t-statistics (eBayes Limma analysis) with false 
discovery rate and adjusted p values<0.05. 
 
Identification of novel target genes of Gli in unstimulated T-cells 
Both transgenic strains carry a transgene encoding Gli2 and share consensus DNA-
binding sequences in target genes.  We aimed to identify potential direct Gli target 
genes in CD4+ T-cells directly ex vivo.  We therefore filtered gene lists by screening 
genes with an expression pattern across genotypes correlating to Ptch1, a canonical Gli 
target gene in T-cells (Furmanski et al., 2013), to identify 33 genes upregulated in 
Gli2A and downregulated in Gli2R unstimulated T-cells (Table I).  We used the 
DAVID v6.7 bioinformatics resource (Huang da et al., 2009) to cluster these genes into 
seven functional groupings according to gene annotations.  Over a third of these genes 
encoded membrane-bound proteins and receptors, several of which are involved in the 
regulation of growth, differentiation or cell death (Igf1r, Ifitm3, C6, Mmp13, Ptlp and 
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Qk), and transport (Slc1a3, Slc25a39, Slc16a9).  Others functional groupings included 
signal transduction, catabolic processes, proteolysis and ion or nucleotide binding.  
Several genes positively regulated by Gli2A have been implicated in T-cell function: 
Rsad2 (viperin) is an anti-viral protein and facilitator of Th2 cytokine production. 
Ifitm3, Hfe and Tnfsf12/TWEAK were also positively regulated by Gli-dependent 
transcription. 
   
We identified six genes downregulated in Gli2A and upregulated in Gli2R unstimulated 
CD4+ cells (see Supplementary Material, Table I).  Hspa1a and Hspa1b are anti-
apoptotic and involved in NFκB activation.  Interestingly, Igfbp4 and Sostdc1 both act 
as BMP or Wnt pathway inhibitors, demonstrating the complex relationship between 
these major morphogenic pathways.  These genes are unlikely to be direct targets of 
Gli2, as expression decreases when the transcriptional activator form of Gli2 is present, 
but may be targets of currently unidentified intermediate repressor genes, which are 
themselves targets of Gli2.  
 
Gli-mediated transcription in resting and activated T-cells controls expression of 
morphogenic, developmental and immune cell signalling genes   
Array data were further analysed using a cut-off of 1.5x fold-change difference in gene 
expression between genotypes, for unstimulated and stimulated datasets (Fig. S1).  
Several hundred genes were regulated by Gli2.  Anti-CD3/CD28 stimulation reduced 
the number of transcripts differentially expressed between genotypes, most likely due to 
the potent effect of TCR signalling on the T-cell transcriptome.  Gli2A and Gli2R 
transgenes may not control expression of an identical set of genes in a reciprocal 
manner, as cellular location, transcription-complex binding partners, stability and 
secondary indirect effects of the Gli2A and Gli2R transcription factor isoforms may 
differ.  To widen our analysis we identified genes differentially expressed in either 
transgenic strain compared to all other samples.  Unstimulated Gli2A T-cells showed 
upregulation of genes encoding important signalling molecules including Tgfb3, Sox4, 
Dusp16 and Hoxa1.  Members of related morphogen signalling pathways including 
Bmpr2 and Wnt5b were also upregulated when Gli2-mediated transcription was active.  
Gli2A expression in T-cells caused downregulation of heat shock protein genes 
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(Hsp90aa1, Hspa1a, Hspa1b), and most interestingly, molecules important in T-cell 
signalling including Jun, Fos, Fosb, Lef1, Ikbkb and Rasgrp1 (Fig. S1, selected genes 
annotated only for clarity).  Sell, encoding CD62L was also downregulated in Gli2A 
cells.  This reflects our observations that Gli2A T-cells express lower levels of cell-
surface CD62L (Fig. 1C,D) and suggests that the CD62L/CD44 phenotype of Gli2A 
CD4+ cells is influenced by Gli2 at a transcriptional level, rather than by shedding of 
CD62L protein (Kahn et al., 1994; Hafezi-Moghadam et al., 2001).  These genes are all 
likely to be targets of intermediate repressor genes, which are themselves targets of 
Gli2.  The expression of Gli2R in T-cells caused downregulation of morphogenic genes 
including Sox6, Fzd7, Hoxd1 and Nkx1.2.  Other genes repressed by Gli2R included 
several with important roles in the regulation of immune cell signalling (Il1b, Cd24a, 
Vsig4, Bcl11a).         
 
When T-cells were stimulated with anti-CD3/CD28 for 6h, we observed that several 
genes upregulated in the Gli2A or downregulated in the Gli2R groups encoded 
molecules involved in immune cell signalling and apoptosis, including Csf2, Cd24a, 
Fasl, and Jdp2.  As in unstimulated Gli2A cells, regulators of morphogenesis, growth 
and/or differentiation (Igf1r, Tgfb3, Hoxa1, Bmpr1b and Sox4) were upregulated in 
stimulated Gli2A cells, and Igfbp4 and Jun were downregulated.  Interestingly, Il6, 
Tgfbi and Il17a were repressed by the presence of Gli2R. (Fig. S1, selected genes only 
are labelled for clarity), suggesting that Gli2-dependent transcription may play a role in 
Th17 cell differentiation.  
Il2ra and Il2 expression was similar in stimulated Gli2A and WT cells, confirming that 
the influence of Gli2A on activation-induced upregulation of cell-surface CD25 and 
intracellular IL-2 protein (Figs. 2-4) is not a direct transcriptional consequence of the 
transgene, but rather the consequence of the overall reduction in T-cell activation.  This 
indicates that the failure of Gli2A cells to fully upregulate CD25 and synthesise IL-2 
(Figs. 2-4) is not an artefact due to constitutive overexpression of Gli2, as expression of 
these genes is not decreased by the presence of Gli2A in T-cells. 
 
We confirmed relative gene expression by qPCR using RNA leftover from array 
experiments (not shown) and from additional samples in independent experiments to 
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validate our microarray results.  Tgfb3, a gene identified in the microarray experiment 
as upregulated in Gli2A cells and downregulated in Gli2R cells compared to WT was 
found to follow this expression pattern in additional samples (Fig. S2A).  This transcript 
encodes TGFβ3, a TGF-beta family member, expressed by CD4+ T-cells and important 
in Th17 cell pathogenesis (Lee et al., 2012).  There is cross-talk between TGFβ and 
Shh/Gli signalling pathways: TGFβ can activate GLI2 expression in several cell types 
(Dennler et al., 2007), and GLI2 directly binds and activates transcription of the TGFB1 
gene in human CD4+ T-cells (Furler and Uittenbogaart, 2012).  Our data strongly 
suggests that Tgfb3, among other TGF-related genes, is a direct transcriptional target of 
Gli2 in murine CD4+ cells, uncovering further overlap of these pathways.    
Rasgrp1 showed the opposite expression pattern: downregulated in Gli2A and 
upregulated in Gli2R cells.  This indicates that its expression is negatively regulated by 
Gli2-mediated transcription (Fig. S2B), most likely via an intermediate repressor gene.   
Other potential Gli-target genes (Fig. S2C: Igf1r, Hoxa1, Ifitm3) or targets of 
intermediate repressors (Fig. S2D: Igfbp4, Ikbkb, Hspa1a, Nfkbiz) were also confirmed 
by qPCR.   
 
Major components of the TCR signalling pathway are differentially expressed when 
Gli2 is active or repressed 
Rasgrp1 encodes an important nucleotide exchange factor that specifically activates 
Ras, a major upstream component of the Erk/MAPK pathway.  Rasgrp1 controls T-cell 
development, differentiation and activation (Reynolds et al., 2004; Priatel et al., 2006; 
Priatel et al., 2010).  We have previously shown defective ERK activation in Gli2A T-
cells (Rowbotham et al., 2007).  Decreased expression of Rasgrp1 (Fig. S2B) could be 
one mechanism by which Gli2A negatively regulates T-cell activation.  Downstream of 
the TCR, Ras-Erk-MAPK signalling culminates in the activation of key T-cell 
transcription factors including AP-1.  We therefore examined the activity of AP-1 by 
EMSA following activation of lymphocytes with anti-CD3/CD28.  Interestingly, we 
found decreased binding of AP-1 probes to Gli2A lymphocyte nuclear extracts 
compared to WT, indicating impaired DNA binding activity of AP-1 in T-cells from 
these mice (Fig. 6B).  AP-1 is made up of complexes of Fos and Jun proteins.  We 
therefore performed gel supershift assays to assess the composition of bound AP-1 in 
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WT, Gli2A and Gli2R cells by blotting with antibodies against cFos, Fos B, Jun B and 
Jun D.  In all cases, Gli2A cells showed decreased activation of these proteins on 
TCR/CD28 ligation (Fig. 6C), consistent with the overall reduction of AP-1 activation 
(Fig. 6A).   In contrast, while overall Gli2R cells showed somewhat decreased AP-1 
activity compared to WT (Fig. 6A), the specific contribution of FosB and JunB to AP-1 
was increased.  Thus, Gli2 activity regulates the expression of these major transcription 
factors in T-cells.   
Ikbkb encodes IKKβ, a protein forming part of the IKK complex, which phosphorylates 
inhibitors of NFκB, allowing translocation of the active NFκB transcriptional complex 
to the nucleus.  Expression of Ikbkb transcript was negatively regulated by Gli2-
mediated transcription (Fig. S2D).  We used Western blotting to examine expression of 
IKKβ protein in WT, Gli2A and Gli2R CD4+ cell lysates.  There was increased 
expression of IKKβ in Gli2R samples whereas Gli2A showed lower levels than the WT 
sample (Fig. 6D).  We therefore examined activity of NFκB in nuclear extracts by 
EMSA.   Binding was severely diminished in the Gli2A sample compared to WT, 
whereas Gli2R extracts showed enhanced binding compared to WT, particularly at the 
lower concentration of stimulating anti-CD3/CD28 antibody (Fig. 6E).   
 
We therefore show that Gli2A activity in T-cells impaired full T-cell activation by at 
least three different mechanisms: 1) diminished calcium flux and decreased nuclear 
NFAT 2) decreased AP-1 activation and 3) impaired activation of NFκB. 
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Discussion  
Here we showed that Gli2A-mediated transcription in T-cells attenuated T-cell 
signalling and T-cell activation on TCR/CD28 ligation.  We investigated the mechanism 
of this effect, and showed that increased Gli2 activation caused a reduction in AP-1 
activation and NF-κB activation downstream of TCR signalling.  In contrast, inhibition 
of physiological Gli2-mediated transcription, in Gli2R cells, led to an increase in NFκB 
activation, and a change in the molecular composition of AP-1.  Impairment of the 
activity of important signalling pathways such as Ras-ERK-AP1 and IKK-NFκB by 
Gli2A would influence T-cell biology, potentially affecting immune cell differentiation 
and adaptive immunity. Subsequent dysregulation of IL-2 receptor 
upregulation/signalling/secretion upon weakened TCR stimulation is likely to further 
limit T-cell responses, providing one explanation for the enhanced apoptosis and 
decreased number of Gli2A T-cells surviving in culture.   
Gli2A cells display normal basal levels of intracellular calcium, however, they lack the 
ability to undergo a full flux compared to WT cells upon TCR stimulation, and show 
decreased nuclear NFAT (Fig. 5).  This may point to defective intracellular calcium 
stores or ion channel pumps and is something that requires further investigation.  The 
alteration of AP-1 and NFκB  activity and impairment of calcium fluxing by Gli-
dependent transcription are important findings, contributing to our understanding of 
how Hh/Gli signals act to ‘tune down’ TCR signalling as observed previously during T-
cell development and activation (Outram et al., 2000; Rowbotham et al., 2007; 
Rowbotham et al., 2008; Rowbotham et al., 2009; Drakopoulou et al., 2010; Furmanski 
et al., 2012).   
 
We have previously reported that Gli2A transcriptional activity in T-cells directly 
increases the production of IL-4 and subsequent expression of Gata3, promoting 
differentiation to the Th2 lineage (Furmanski et al., 2013).  It is interesting to note that 
differentiation of naïve CD4+ T-cells to Th2 cells is associated with lower TCR signal 
strength.  TCR signals triggered by low cognate peptide concentration stimulate weak 
and transient ERK activation, allowing Gata3 and Il4 expression, which favours Th2 
differentiation (Yamane et al., 2005).  Therefore, another mechanism for Gli2A to 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
promote Th2 differentiation is by decreasing the strength of the TCR signal, via 
attenuation of ERK activation.       
 
Microarray profiling revealed additional wide-ranging effects of Gli2-driven 
transcription on T-cell gene expression, including positive regulation of several genes 
involved in T-cell function.  These include Tgfb3, important in Th17-mediated 
autoimmunity (Lee et al., 2012), Igf1r, expressed highly in T-ALL (Medyouf et al., 
2011), Rsad2 (viperin) a regulator of viral infection (Seo et al., 2011), Cd24a, important 
in T-cell homeostasis (Li et al., 2004) and Dusp16, a negative regulator of JNK in T-
cells (Kumabe et al., 2010).  It therefore seems likely that Hh/Gli signalling may play 
uncharacterised roles in the modulation of autoimmunity and response to infection.    
 
Hh/Gli-related molecules or genes involved in development and oncogenesis in other 
tissues were also found to be differentially regulated in Gli2A/Gli2R T-cells including 
Ptch, Bmpr2, Wnt5b, Hoxa1 and Sox4.  Our data and others (Lowrey et al., 2002) 
indicate a role for Hh/Gli in modulating cell division and apoptosis.  It is therefore 
timely and important to examine the role of Hh/Gli signalling in T-cell malignancies, 
particularly as subtypes of lymphocytic leukaemia have been shown to have differing 
Hh-dependency (Decker et al., 2012). 
 
The role of Hh signalling in influencing the outcome of peripheral T-cell activation in 
both human and mouse is controversial.  In some studies, addition of recombinant Shh 
to T-cell cultures activated with sub-optimal concentrations of anti-CD3/CD28 led to 
increased activation and proliferation, whereas anti-Hh antibody reduced cell 
proliferation (Lowrey et al., 2002; Chan et al., 2006).  However, conditional deletion of 
Smo or Ptch1 had no significant effect on T-cell proliferation kinetics when anti-CD3 
stimulating antibody were used in vitro (El Andaloussi et al., 2006; Michel et al., 2013).  
Our data shows that Gli2-mediated transcription attenuates T-cell activation and 
proliferation.  Our current and previous studies (Rowbotham et al., 2007; Rowbotham et 
al., 2008) largely use a T-cell-specific transgenic approach, in order to rule out cell-
extrinsic secondary mechanisms and non-specific effects from high concentrations of 
recombinant protein, such as those from suspected endotoxin contamination of 
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commercially-available rShh (Wakelin et al., 2008).  Additionally, there is emerging 
evidence in some cell types for non-canonical Hh/Gli signalling: Smo-independent 
signalling, Hh-dependent Smo-dependent Gli-independent signalling, and Hh-
independent activation of Gli transcription (Hui and Angers, 2011; Brennan et al., 
2012).  Our Gli2A/Gli2R systems are designed to investigate the specific influence of 
Gli-mediated transcription on T-cell gene expression and function.  This will reflect Hh-
dependent transcription, as Gli-mediated transcriptional activation is downstream of 
canonical Hh signalling.  Indeed, we have previously shown that canonical Hh target 
genes are up- and down-regulated in Gli2A and Gli2R cells respectively, and that in T-
cells, Smo mimics this expression pattern (Furmanski et al., 2013).  However, as T-cells 
lack cilia (Finetti et al., 2011), there are likely to be differences in Hh signal 
transduction in T-cells compared to ciliated cells.  In ciliated cells, on ligand binding to 
Ptch, the signal transduction molecule Smo is trafficked along the primary cilium, and 
movement of Smo is believed to be essential for signalling (Rohatgi et al., 2007).  In the 
case of T-cells, the absence of cilia could explain apparent inconsistencies between 
conditional-Smo-/- (El Andaloussi et al., 2006), conditional Ptch-/- (Michel et al., 2013) 
and Gli2A/R-transgenic models.  Further, the potential for activation of Gli proteins by 
non-Hh signalling pathways such as through TGFβ signalling could explain 
discrepancies in observations made in Gli2A/R systems and those using recombinant 
Hh protein in cell culture.  These questions require further investigation.  
 
The specific activity of morphogens like Hh family proteins varies with cellular context.  
The complex role for Hh/Gli signalling in T-cell activation requires further dissection, 
and may have wide-ranging effects on the immune response in health and disease.  
Increased expression of Hh protein or other molecules that can trigger Gli activity 
during tissue renewal could attenuate local T-cell responses, potentially aiding repair or 
skewing local immune responses.  We have previously shown that Hh proteins are 
upregulated in the lung following the induction of allergic lung disease (Furmanski et 
al., 2013), and Shh is known to be upregulated in chronic pulmonary fibrosis (Stewart et 
al., 2003), in inflammatory gut disease (Nielsen et al., 2004), in wound healing (Le et 
al., 2008) and after tissue ischemia (Pola et al., 2003).  Importantly, many cancers 
overexpress Hh ligands (Jiang and Hui, 2008).  In addition to its oncogenic functions, 
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our work suggests that Hh may also signal to local T-cells to decrease activation.  Hh-
driven suppression of a local T-cell immune response could uncover a previously 
unknown but targetable role for Hh/Gli in anti-tumour immunity.          
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Materials and Methods 
Mice 
Lck-Gli2ΔN2 (Gli2A) (Rowbotham et al., 2007) and Lck-Gli2ΔC2 (Gli2R) 
(Rowbotham et al., 2008) C57BL/6-background transgenic mice were as described.  All 
experiments were performed with littermate/age-matched control mice under the ethical 
authority of the United Kingdom Home Office and local regulations. 
 
Cell culture 
T-cell activation: 5x106/ml splenic cells were cultured in AIMV medium (Invitrogen) 
with 10-5M β-mercaptoethanol (Sigma-Aldrich, UK) with/without soluble anti-CD3 and 
anti-CD28 (BD Pharmingen, UK, 0.01 μg/ml unless otherwise stated) or anti-
CD3/CD28-coated beads (1:1 bead:cell ratio, Invitrogen Life Tech, UK), with/without 
recombinant mouse IL-2 (Roche, UK, 10 U/ml) or Shh (R&D Systems, UK, 300 
ng/ml).  Magnetic bead separation was performed using EasySep CD4+ cell negative 
selection (StemCell Tech, France) according to the manufacturers’ instructions. 
 
Flow cytometry, ELISA and antibodies 
Cells were stained and analysed as described (Furmanski et al., 2013) on a BD C6 
Accuri flow cytometer.  CFSE labelling (10µM in PBS) was performed as described 
(Rowbotham et al., 2007).  Ic-cytokine and AnnexinV staining was performed using 
eBiosciences UK Fix/Perm and Permeablisation buffers and AnnV binding buffers 
respectively.  PI staining was performed in PBS immediately after cell surface staining, 
using 0.5-1.0µg/ml PI (Sigma).  Intracellular phospho-protein staining was performed 
using commercial buffers: BD Lyse/Fix and Permeablisation Buffer III (BD Biosceince, 
UK) according to the manufacturers’ instructions.  ELISA were performed using 
eBioscience Ready-Set-Go mouse IL-2 kits (Affymetrix, UK).  Data represent at least 
three experiments. 
 
Calcium flux 
Splenocytes (1-2x106) were loaded with 3µM Fluo-4-AM (Life Tech, UK) in DMEM 
(Gibco, Life Tech, UK) for 30min at 37⁰C, washed twice, surface-stained and washed.  
Cells for TCR stimulation were additionally surface stained with hamster anti-CD3 
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(3µg/106 cells, BD, UK) and washed.  All cells were resuspended in PBS containing 
Ca2+/ Mg2+ (Gibco, Life Tech, UK) and incubated at 37⁰C until acquisition.  Data were 
acquired on a BD C6Accuri flow cytometer for 60s prior to addition of stimuli (<9 µg 
anti-hamster IgG, Vector Labs UK; or 100 ng/ml Ionomycin, Sigma, UK).   
 
Microarray and data analysis 
Array experiments were performed as described (Furmanski et al., 2013).  Briefly, total 
RNA was extracted from purified fresh (unstimulated) or 6h activated (stimulated) 
CD4+ spleen cells of WT (n=3), Gli2A (n=3) and Gli2R (n=3) and was submitted to 
UCL Genomics for processing and quality control prior to hybridisation to Affymetrix 
MOE430 2.0 mouse whole genome array chips and data acquisition according to 
standard Affymetrix protocols.  All microarray data are publicly available (dataset: 
GSE33156, GEO depository).   
 
Quantitative real time RT-PCR (qPCR) 
qPCR was carried out in triplicate as described (Furmanski et al., 2013).  Pre-validated 
transcript-specific oligonucleotides (Quantitect Primer Assays, Qiagen, UK) were used 
except: Hoxa1F CAGGGAAAGTTGGAGAGTACG Hoxa1R 
TCTGCTTCATGCGGCGATTCTG.  Data were normalised to expression of Hprt and 
represent at least two independent experiments. 
 
Western Blot 
CD4+ cells from spleen (n=3 mice) were purified as described and pooled for each 
group.  Protein expression was analysed in nuclear or cell lysates by Western blotting 
with appropriate antibody (anti-Gli1 (H-300); -Gli2 (H-300); -IKKβ (H-470); all Santa 
Cruz, UK); -NFAT2 (D15F1, Cell Signalling Tech, UK)  or control (anti-vinculin, Cell 
Signaling Tech; -laminA, Millipore; or –actin, Santa Cruz) as previously described 
(Bellavia et al., 2000; D'Acquisto et al., 2007). Briefly, cells were lysed in ice-cold lysis 
buffer (1% NP-40, 20 mM Tris pH 7.5, 150 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 0.5 
mM PMSF, 1 μM Aprotinin, 1 μM Leupeptin, 1 μM Pepstatin, 50 mM NaF, 10 mM 
Na4P2O7, and 1 mM NaVO4, 1 mM β-glycerophosphate). Cell lysates were 
centrifuged at 14,000 rpm for 5 min at 4°C and the supernatants collected and subjected 
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to electrophoresis on SDS-10% polyacrylamide gel. Membranes were incubated 
overnight with antibodies diluted in Tris-buffered saline solution containing Tween-20 
with 5% non-fat dry milk at 4°C. In all cases, prior to Western blotting, protein 
concentration in cell extracts was quantified using a colorimetric Protein Assay kit with 
reference to a BSA standard curve (Biorad, UK), according to the manufacturers’ 
instructions.  This information was used to load equivalent amounts of protein on to 
gels, which was confirmed using loading controls. 
 
EMSA & Supershift 
LN cells of three mice per group and nuclear extracts probed by electro-mobility shift 
assays to analyse DNA binding of AP-1 or NFκB, as previously described (D'Acquisto 
et al., 2007).  Briefly, nuclear extracts (3 to 5 g) were incubated with 2 g of poly 
(dI:dC) in 20 l of binding buffer with 32P end-labeled, double –stranded 
oligonucleotide probes (5x105 cpm), and fractionated on a 6% polyacrylamide gel (29:1 
cross-linking ratio) in 0.5% TBE for 2.5 hr at 150 volts. Double–stranded 
oligonucleotide probes were from Promega, UK.  Supershift EMSA were performed as 
above, additionally using the following antibodies: anti-cFos, -FosB, -JunB, -JunD (all 
Cell Signaling Tech.) 
 
Data analysis 
Statistical analyses were performed using Microsoft Excel or Prism 4 (Graph Pad).  
Two-tailed unpaired Student’s t-tests were used to assess statistical significance to 
p<0.05.  
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Figures 
 
 
 
Figure 1: CD4+ T-cell phenotype of Gli2A mice 
(a) Western blotting with anti-Gli2 or -Gli1 on cell extracts from purified CD4+ 
splenocytes of WT and Gli2A mice. Nuclear control: anti-laminA; cytoplasmic control: 
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anti-vinculin.  (b) Mean±s.e.m. number of CD4+ lymphocytes in spleen of WT (n=14) 
and Gli2A (n=15) mice. (c) Histograms showing representative expression of CD3 and 
CD69 on CD4+ T-cells from spleen of WT and Gli2A mice.  %CD3+ or %CD69+ are 
indicated, MFI of anti-CD3 staining is show in italics (n=7 pairs, %CD3+ p<0.03; MFI 
CD3+ & %CD69+ p=n/s). (d) Representative CD62L/CD44 expression profiles on 
splenic CD4+ cells and (e) Mean%±s.e.m. of CD4+ T-cells from WT (n=5) and Gli2A 
(n=5) spleen that are CD62LhiCD44- (naïve, p=0.03), CD62L+CD44+ (central 
memory, CM) and CD62L-CD44+ (effector memory). (f) Histograms show CD62L 
expression on CD4+ T-cells with MFI in italics (Con = unstained control), 
representative example of n=5 pairs, p<0.002.   
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Figure 2: Gli2-mediated transcription attenuates T-cell activation kinetics 
 (a, b) Gli2A and WT splenocytes were cultured with 0.01μg/ml anti-CD3/CD28 for 
three days.  Cells were stained with anti-CD25 and anti-CD4.  (a) Expression of CD25 
on CD4+ cells after 3 days.  Histograms show %CD25+ cells in WT (solid line) and 
Gli2A (dotted line).  (b) Chart shows mean%±s.e.m.  of CD4+ T-cells that express cell-
surface CD25 (n=3 mice/group, *p<0.05).  (c) CD4+ cell division measured by CFSE 
dilution 72h after activation with anti-CD3/CD28.  Histogram bar and label shows 
%cells undivided, (d)  Mean%±s.e.m.  undivided CD4+ cells after 72 hours in WT and 
Gli2A activation cultures, n=4, *p=0.04. 
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Figure 3: Gli2A-driven transcription enhances apoptosis and impairs IL-2-
responsiveness during division 
(a) Mean%±s.e.m. CD4+AnnexinV+ (AnnV+, early apoptotic cells) in live gate from 
splenocyte activation cultures (24h, n=5 experiments, *p=0.02) and (b) %CD4+AnnV+ 
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cells in unstimulated cultures (72h, n=3, *p=0.02).  (c) Propidium Iodide (PI) staining of 
CD4+ splenocytes 24h after stimulation with anti-CD3/CD28 (0, 0.01, 0.1 or 1.0 µg/ml; 
0 = unstimulated). Histograms are representative of two experiments, dotted: 
background staining, dark-grey: WT, light-grey: Gli2A.  (d) Intracellular IL-2 staining 
in fresh CD4+ splenocytes following 3h activation with PMA (50ng/ml), Ionomycin 
(500ng/ml) plus Brefeldin A (2ng/ml).  Bars on shaded histograms show %+IL-2+ and 
IL-2hi, gated on CD4+cells, dashed grey line shows background staining.  
Representative example shown of five experiments (IL-2hi, WT: 25.0%±0.6, Gli2A: 
19.9±1.5, p=0.009).  (e) Purified CD4+ cells were cultured with anti-CD3/CD28-coated 
beads for up to three days.  Surface CD25 and intracellular IL-2 were measured by flow 
cytometry at the times indicated, %CD25+IL-2+ cells (large gate) and %CD25+IL-2hi 
cells (smaller gate, labelled in italic numerals). Gates were set according to isotype 
control staining of CD4+ cells (lower panels).  Representative of three experiments 
(n=3, WT vs. Gli2A %CD25+IL-2+ at 48h time-point p<0.01).  (f) ELISA showing 
mean±s.e.m.  IL-2 produced by purified CD4+ cells cultured with anti-CD3/CD28-
coated beads (WT n=5, Gli2A n=4, *p=0.04). 
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Figure 4: Gli2-dependent transcription decreases IL-2 production and CD25 (IL2R) 
upregulation 
(a) Histograms representing dye dilution measured by flow cytometry over time in 
CFSE-loaded CD4+ splenocytes activated with 0.01μg/ml anti-CD3/CD28 without 
(stim, black line) or with 10U/ml rIL-2 (stim+IL-2, shaded).  Histograms show overlays 
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of stimulated and stimulated+IL-2 cultures, bar markers show peak representing the 
undivided population.  (b) Flow Jo software was used to calculate cell proliferation in 
cultures.  Number of cells in each generation (peak) was estimated and the relative 
effect of IL-2 on cultures was calculated.  Bar chart shows number of cells undergoing 
more than three divisions in stim+IL-2 cultures relative to stim alone (mean±s.e.m.  n=4 
pairs, *p=0.001).  (c) Number of live CD4+ cells remaining in culture at 72h (n=3, 
*p<0.03) and (d) Phospho-STAT5 staining in CD4+ splenocytes unstimulated (left 
panels) or following 15min culture with 10ng/ml IL-2 (right panels: WT n=3, 8.9±1.5%; 
Gli2A n=4, 8.4±1.6%, p=n/s).  (e) Phospho-STAT5 staining in CD4+ splenocytes 
cultured for 48h with IL-2 or anti-CD3/CD28+IL-2.  Histograms show %pSTAT5+ 
cells and are representative of two independent experiments: WT (dark-grey) and Gli2A 
(light-grey).    
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Figure 5: Gli-mediated transcription regulates the T-cell calcium flux 
 (a) Splenocytes were loaded with Fluo-4-AM (3µM) and surface stained.  Cells were 
incubated with hamster anti-mouse CD3 (3µg/106) for 20min on ice, washed, 
resuspended in PBS containing calcium and incubated at 37⁰C prior to acquisition by 
flow cytometry.   Cells were stimulated with 9µg cross-linking anti-hamster IgG, or 
0.1µg/ml Ionomycin.  Fluorescence intensity in FL-1 (Fluo-4-AM) was recorded during 
the (b, n=5, *p=0.03) 60s baseline and for a further 4min through the peak of flux.  The 
relative change in MFI (100x(peak-baseline)/baseline) was calculated (%flux) for (b,c) 
WT and Gli2A (Mean±s.e.m., *p=0.02).  (d) Western blotting of NFAT2 in nuclear 
extracts from purified CD4+ cells, which were activated for 24h with 2.5µg/ml plate-
bound anti-CD3/CD28. Loading control: anti-laminA. 
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 Figure 6: Gli2A-driven transcription attenuates expression and DNA binding activity of 
key T-cell transcription factors  
(a) Western blotting as in Fig. 1a on extracts from purified CD4+ cells from WT and 
Gli2R mice.   (b) AP-1 activity was assessed by EMSA in lymphocytes from WT (n=3), 
Gli2R (n=3) and Gli2A (n=3) mice activated with 1.25, 2.5 and 5µg/ml plate-bound 
anti-CD3/CD28.  (c) Supershift assays were performed with anti-Fos and anti-Jun 
antibodies following EMSA.  (d) Protein expression of the IKKβ subunit was assessed 
by Western blotting of CD4 cell lysates from WT (n=3), Gli2R (n=3) and Gli2A (n=3), 
anti-actin blotting was performed as loading control.  (e) NFκB activity was probed by 
EMSA as described above, where cells were activated with 2.5µg/ml or 5µg/ml as 
stated.  
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